Quinn Opportunity Partners’s Pfizer PFE Stock Holding History

Quinn Opportunity Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9M	Sell	536,728 -25,000	-4%	-$654K	0.6%	42
2026 Q1	$15.8M	Hold	561,728	–	–	0.82%	32
2025 Q4	$14M	Hold	561,728	–	–	0.59%	37
2025 Q3	$14.3M	Hold	561,728	–	–	1.01%	17
2025 Q2	$13.6M	Hold	561,728	–	–	1.14%	14
2025 Q1	$14.2M	Buy	561,728 +4,000	+0.7%	+$105K	0.98%	23
2024 Q4	$14.8M	Buy	557,728 +104,818	+23%	+$2.84M	1%	24
2024 Q3	$13.1M	Hold	452,910	–	–	1.27%	21
2024 Q2	$12.7M	Buy	452,910 +4,000	+0.9%	+$110K	1.44%	18
2024 Q1	$12.5M	Buy	448,910 +20,000	+5%	+$555K	1.38%	21
2023 Q4	$12.3M	Buy	428,910 +144,000	+51%	+$4.35M	1.28%	18
2023 Q3	$9.45M	Buy	284,910 +4,000	+1%	+$141K	1.22%	17
2023 Q2	$10.3M	Buy	+280,910	New	+$10.9M	1.4%	18
2021 Q4	–	Sell	-80,000	Closed	-$3.44M	–	254
2021 Q3	$3.44M	Buy	+80,000	New	+$3.54M	0.22%	90
2021 Q2	–	Sell	-21,000	Closed	-$761K	–	250
2021 Q1	$761K	Buy	+21,000	New	+$746K	0.05%	168

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quinn Opportunity Partners's PFE Position: Q2 2026 in Review

Quinn Opportunity Partners reduced its Pfizer (PFE) stake by 4.5% in Q2 2026, selling an estimated $654K and leaving 536,728 shares worth $12.9M. The position accounts for 0.6% of the portfolio, ranked #42.

Quinn Opportunity Partners first reported a position in PFE in Q1 2021 and has held it in 15 quarters since. The position peaked at $15.8M in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Quinn Opportunity Partners held 536,728 shares of Pfizer worth $12.9M as of Q2 2026.
Quinn Opportunity Partners sold 25,000 Pfizer shares in Q2 2026, an estimated $654K.
Pfizer made up 0.6% of Quinn Opportunity Partners's portfolio in Q2 2026, its #42 holding.
Quinn Opportunity Partners first reported a position in Pfizer in Q1 2021 and has held it in 15 quarters since.
Quinn Opportunity Partners's Pfizer position peaked at $15.8M in Q1 2026.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.